FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Adamas Announces Two Data Presentations on ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) at the 20th International Congress of Parkinson’s and Movement Disorders
May 16, 2016
from Market Exclusive
Adamas Announces Positive Top-line Results from its Phase 3 EASE LID 3 Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients with Parkinson’s Disease
April 28, 2016
BRIEF-Adamas Pharma announces additional ADS-5102 data for treatment of Levodopa-induced Dyskinesia
June 22, 2016
7 Biotechnology Stocks to Buy Now
May 30, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here